In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes

[1]  P. Garnero.  New developments in biological markers of bone metabolism in osteoporosis. , 2014, Bone.

[2]  F. Conversano,et al.  Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques. , 2013, World journal of radiology.

[3]  S. Cummings,et al.  Treat-to-target for osteoporosis: is now the time? , 2013, The Journal of clinical endocrinology and metabolism.

[4]  Thomas M Link,et al.  osteoporosis imaging : State of the Art and Advanced Imaging 1 , 2022 .

[5]  E. Luo,et al.  The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats , 2012, Osteoporosis International.

[6]  U. P. S. T. Force,et al.  Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement , 2011, Annals of Internal Medicine.

[7]  Fang-Ping Chen,et al.  Effect of estrogen on the activity and growth of human osteoclasts in vitro. , 2009, Taiwanese journal of obstetrics & gynecology.

[8]  R. Eastell,et al.  Biomarkers of bone health and osteoporosis risk* , 2008, Proceedings of the Nutrition Society.

[9]  C. Cooper,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.

[10]  V. Castronovo,et al.  A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden. , 2007, Cancer research.

[11]  R. McCormick.  Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. , 2007, Alternative medicine review : a journal of clinical therapeutic.

[12]  D. Brömme,et al.  The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. , 2005, Advanced drug delivery reviews.

[13]  D. Fishman,et al.  Matrilysin (MMP‐7) promotes invasion of ovarian cancer cells by activation of progelatinase , 2005, International journal of cancer.

[14]  G. Pescarmona,et al.  Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  P. Delmas,et al.  Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. , 2004, Journal of musculoskeletal & neuronal interactions.

[16]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[17]  M. Brown,et al.  Osteoclast formation from circulating precursors in osteoporosis , 2003, Scandinavian journal of rheumatology.

[18]  D. Fisher,et al.  Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease. , 2002, Current molecular medicine.

[19]  P. Saftig,et al.  The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  E. Vuorio,et al.  Accelerated Turnover of Metaphyseal Trabecular Bone in Mice Overexpressing Cathepsin K , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  S. Davidge,et al.  A comparison of ovariectomy models for estrogen studies. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  D. Lacey,et al.  Characterization of osteoclast precursors in human blood , 2000, British journal of haematology.

[23]  M. Brandi,et al.  Discriminant capacity of quantitative ultrasound versus dual X-ray absorptiometry to determine cancellous bone loss in ovariectomized rats. , 2000, Bone.

[24]  M. Karsdal,et al.  Proteinases in bone resorption: obvious and less obvious roles. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[25]  G D Roodman,et al.  Cell biology of the osteoclast. , 1999, Experimental hematology.

[26]  A. Flanagan,et al.  Human osteoclasts derive from CD14‐positive monocytes , 1999, British journal of haematology.

[27]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Sloane,et al.  The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. , 1997, Cancer research.

[29]  C. Shih,et al.  Peripheral blood mononuclear cells develop into multinucleated osteoclasts in tissue culture , 1996, The Anatomical record.

[30]  G. Bilbe,et al.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. , 1995, Biochemical and biophysical research communications.

[31]  R. Dodds,et al.  Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. , 1992, Journal of cell science.

[32]  R. Mieremet,et al.  Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones , 1987, Cell and Tissue Research.

[33]  B. Samuelsson,et al.  Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts. , 2008, Bone.

[34]  Zhao Haibo,et al.  Expression of matrix metalloproteinase-9 mRNA in osteoporotic bone tissues , 2008, Journal of Tongji Medical University.

[35]  Albert Hofman,et al.  Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. , 2004, The Journal of clinical endocrinology and metabolism.

[36]  B. Troen.  The role of cathepsin K in normal bone resorption. , 2004, Drug news & perspectives.

[37]  Albert Hofman,et al.  Height in Pre- and Postmenopausal Women Is Influenced by Estrogen Receptor α Gene Polymorphisms , 2004 .

[38]  K. Irie,et al.  Effects of running exercise on the mandible and tibia of ovariectomized rats , 2001, Journal of Bone and Mineral Metabolism.

[39]  S. Reddy,et al.  Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen. , 1999, Endocrinology.

[40]  D. Lacey,et al.  Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors , 1999, Journal of cellular biochemistry.